Symptoms and causes

Symptoms

Long-term infection with the hepatitis C virus (HCV) is known as chronic hepatitis C. Chronic hepatitis C is usually a "silent" infection for many years, until the virus damages the liver enough to cause the signs and symptoms of liver disease. Among these signs and symptoms are:

  • Bleeding easily
  • Bruising easily
  • Fatigue
  • Poor appetite
  • Yellow discoloration of the skin and eyes (jaundice)
  • Dark-colored urine
  • Itchy skin
  • Fluid buildup in your abdomen (ascites)
  • Swelling in your legs
  • Weight loss
  • Confusion, drowsiness and slurred speech (hepatic encephalopathy)
  • Spider-like blood vessels on your skin (spider angiomas)

Every chronic hepatitis C infection starts with an acute phase. Acute hepatitis C usually goes undiagnosed because it rarely causes symptoms. When signs and symptoms are present, they may include jaundice, along with fatigue, nausea, fever and muscle aches. Acute symptoms appear one to three months after exposure to the virus and last two weeks to three months.

Acute hepatitis C infection doesn't always become chronic. Some people clear HCV from their bodies after the acute phase, an outcome known as spontaneous viral clearance. In studies of people diagnosed with acute HCV, rates of spontaneous viral clearance have varied from 14 to 50 percent. Acute hepatitis C also responds well to antiviral therapy.

Causes

Hepatitis C infection is caused by the hepatitis C virus. The infection spreads when blood contaminated with the virus enters the bloodstream of an uninfected person.

Globally, HCV exists in several distinct forms, known as genotypes. The most common HCV genotype in North America and Europe is type 1. Type 2 also occurs in the United States and Europe, but is less common than type 1. Both type 1 and type 2 have also spread through much of the world, although other genotypes cause a majority of infections in the Middle East, Asia and Africa.

Although chronic hepatitis C follows a similar course regardless of the genotype of the infecting virus, treatment recommendations vary depending on viral genotype.

Risk factors

Your risk of hepatitis C infection is increased if you:

  • Are a health care worker who has been exposed to infected blood, which may happen if an infected needle pierces your skin
  • Have ever injected or inhaled illicit drugs
  • Have HIV
  • Received a piercing or tattoo in an unclean environment using unsterile equipment
  • Received a blood transfusion or organ transplant before 1992
  • Received clotting factor concentrates before 1987
  • Received hemodialysis treatments for a long period of time
  • Were born to a woman with a hepatitis C infection
  • Were ever in prison
  • Were born between 1945 and 1965, the age group with the highest incidence of hepatitis C infection

Complications

Hepatitis C infection that continues over many years can cause significant complications, such as:

  • Scarring of the liver (cirrhosis). After 20 to 30 years of hepatitis C infection, cirrhosis may occur. Scarring in your liver makes it difficult for your liver to function.
  • Liver cancer. A small number of people with hepatitis C infection may develop liver cancer.
  • Liver failure. Advanced cirrhosis may cause your liver to stop functioning.
July 26, 2016
References
  1. Hepatitis C FAQs for the public. Centers for Disease Control and Prevention. http://www.cdc.gov/hepatitis/hcv/cfaq.htm. Accessed May 4, 2016.
  2. AskMayoExpert. Hepatitis C antiviral therapy (adult). Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2015.
  3. Florian J, et al. Direct-acting antiviral drugs for treatment of chronic hepatitis C infection: Interferon-free is now. Clinical Pharmacology and Therapeutics. 2015;98:394.
  4. Recommendations for testing, managing, and treating hepatitis C. Alexandria, Va.: The American Association for the Study of Liver Diseases. Arlington, Va.: The Infectious Diseases Society of America. http://www.hcvguidelines.org/. Accessed March 28, 2016.
  5. Liese MD (expert opinion). Mayo Clinic, Rochester, Minn. May 31, 2016.
  6. Bennett JE, et al. Hepatitis C. In: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 8th ed. Philadelphia, Pa.: Churchill Livingstone Elsevier; 2015. https://www.clinicalkey.com. Accessed May 4, 2016.
  7. Chopra S, et al. Clinical manifestations and natural history of chronic hepatitis C virus infection. http://www.uptodate.com/home. Accessed June 1, 2016.
  8. Hepatic Encephalopathy. What are the symptoms of HE? American Liver Foundation. http://he123.liverfoundation.org/diagnosis/symptoms-of-he/. Accessed Dec. 1, 2014.
  9. Lorenz R, et al. Clinical manifestations, diagnosis, and treatment of acute hepatitis C in adults. http://www.uptodate.com/home. Accessed April 3, 2016.
  10. AskMayoExpert. Hepatitis C epidemiology (adult). Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2015.
  11. Venkatesh SK, et al. Magnetic resonance elastography of the liver: Technique, analysis and clinical applications. Journal of Magnetic Resonance Imaging. 2013;37:544.
  12. Gerstenmaier JF. Ultrasound in chronic liver disease. Insights Into Imaging. 2013;5:441.
  13. What I need to know about hepatitis C. National Institute of Diabetes and Digestive and Kidney Diseases. http://www.niddk.nih.gov/health-information/health-topics/liver-disease/hepatitis-c/Pages/ez.aspx. Accessed June 1, 2016.
  14. Verna EC. Recurrence of hepatitis C virus infection following liver transplantation. http://www.uptodate.com/home. Accessed March 22, 2016.
  15. Brown A. Decision Support System. Mayo Clinic, Rochester, Minn. March 22, 2016.
  16. AskMayoExpert. Hepatitis C emerging treatments (adult). Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2015.